Aura Biosciences, Inc. (AURA): Price and Financial Metrics

Aura Biosciences, Inc. (AURA): $10.15

0.29 (-2.78%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add AURA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#96 of 328

in industry

AURA Price/Volume Stats

Current price $10.15 52-week high $12.38
Prev. close $10.44 52-week low $5.99
Day low $10.14 Volume 138,200
Day high $10.64 Avg. volume 176,124
50-day MA $9.27 Dividend yield N/A
200-day MA $8.25 Market Cap 503.50M

AURA Stock Price Chart Interactive Chart >


Aura Biosciences, Inc. (AURA) Company Bio


Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.


AURA Latest News Stream


Event/Time News Detail
Loading, please wait...

AURA Latest Social Stream


Loading social stream, please wait...

View Full AURA Social Stream

AURA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!